Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Yкраїнський (UK)
Przejdź do strony domowej biblioteki Centralna Biblioteka Wojskowa Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaCentralna Biblioteka Wojskowa

Wyszukujesz frazę "modified nucleosides" wg kryterium: Temat

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-4 z 4
    Tytuł:
    Aktywność biologiczna modyfikowanych nukleozydów. Część 3
    Biological activity of modified nucleosides. Part 3
    Autorzy:
    Szlenkier, M.
    Powiązania:
    https://bibliotekanauki.pl/articles/171517.pdf
    Data publikacji:
    2018
    Wydawca:
    Polskie Towarzystwo Chemiczne
    Tematy:
    nukleozydy modyfikowane
    aktywność biologiczna
    cele molekularne
    mechanizm działania
    modified nucleosides
    biological activity
    molecular targets
    mechanism of action
    Opis:
    Part III of the review devoted to biological activities of nucleoside derivatives presents a further description of analogues modified in the sugar residue with particular focus on those with altered configuration in the 2’ or 3’ position, e.g. cytarabine – an old anticancer chemotherapy agent used to treat acute myeloid leukemia, acute lymphoblastic leukemia, and non-Hodgkin’s lymphomas; fludarabine – derivative of vidarabine used as a drug in the treatment of chronic lymphocytic leukemia, and non-Hodgkin lymphomas; clofarabine – approved by the FDA in 2004, a new-generation second-line drug for recurrent acute myeloid leukemia; and fialuridine – examined as a potential therapeutic for the treatment of HBV infection, however, clinical trials ended tragically. In the last section of the review derivatives with other modifications in the sugar moiety are described – carbocyclic and acyclic analogues, l-nucleosides and 5’-modified nucleosides. Among others, very important modified nucleosides are listed e.g. acyclovir, ganciclovir, DHPA, tenofovir, cyclopentenylcytosine, entecavir, carbovir, abacavir, lamivudine, telbivudine and sinefungin VA. All parts together make a possibly complete and concise review, including the latest reports, the most important groups of modified nucleosides, and should be considered as a whole. In the context of the activities description, there are references to the important molecular targets, mechanisms of action, pharmacodynamics, pharmacokinetics, toxicity, resistance, in vitro and in vivo tests or prodrug strategies, which can be a starting point for further study for chemists interested in medicinal chemistry.
    Źródło:
    Wiadomości Chemiczne; 2018, 72, 9-10; 767-787
    0043-5104
    2300-0295
    Pojawia się w:
    Wiadomości Chemiczne
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
    Tytuł:
    Aktywność biologiczna modyfikownych nukleozydów. Część 1
    Biological activity of modified nucleosides. Part 1
    Autorzy:
    Szlenkier, M.
    Powiązania:
    https://bibliotekanauki.pl/articles/172790.pdf
    Data publikacji:
    2018
    Wydawca:
    Polskie Towarzystwo Chemiczne
    Tematy:
    nukleozydy modyfikowane
    aktywność biologiczna
    cele molekularne
    mechanizm działania
    modified nucleosides
    biological activity
    molecular targets
    mechanism of action
    Opis:
    Every year, hundreds of new nucleoside analogues are obtained in laboratories around the world. As early as in 1964, 3’-azidothymidine (AZT) was first synthesized, which turned out to be the main weapon in the fight against HIV viruses 20 years later. Part I of the review includes nucleosides possessing modifications in the base moiety or having other heterocyclic bases. Nucleosides modified in the sugar residue, because of a broad spectrum of examples, will be a subject of part II and III of the review. In the group of analogues modified in the base moiety the following derivatives among others are listed: 5-iodo-2’-deoxyuridine (IDU), E-5-(2- bromovinyl)-2’-deoxyuridine (BVDU), capecitabine – prodrug form of fluorouracil, 7-deazaadenosine, BCX4430 (immucillin-A) – 9-deazaadenosine derivative active against filoviruses such as Ebola virus (EBOV). In the group of nucleosides having a different heterocyclic base the following derivatives are listed: ribavirin (RBV) and its analogues – RBV triphosphate is an inhibitor of many viral enzymes involved in the replication cycle, mizoribine (MZB) – a naturally occurring nucleosidic immunosuppressor, 5-ethynyl-1-β-"-ribofuranosyl-imidazole-4-carboxamide (EICAR) which suppresses development of murine leukemia cell lines and has a broad spectrum of activity against RNA and DNA viruses. The C-nucleosides group includes e.g. oxazinomycin – a natural antibiotic with growth inhibitory properties against gram (+), gram (–) bacteria and sarcoma, and formycin A isolated from Streptomyces lavendulae, which has cytostatic and antiviral activity.
    Źródło:
    Wiadomości Chemiczne; 2018, 72, 3-4; 109-126
    0043-5104
    2300-0295
    Pojawia się w:
    Wiadomości Chemiczne
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
    Tytuł:
    Aktywność biologiczna modyfikownych nukleozydów. Część 2
    Biological activity of modified nucleosides. Part 2
    Autorzy:
    Szlenkier, M.
    Powiązania:
    https://bibliotekanauki.pl/articles/171742.pdf
    Data publikacji:
    2018
    Wydawca:
    Polskie Towarzystwo Chemiczne
    Tematy:
    nukleozydy modyfikowane
    aktywność biologiczna
    cele molekularne
    mechanizm działania
    modified nucleosides
    biological activity
    molecular targets
    mechanism of action
    Opis:
    Part II of the review describes biological activities of nucleosides modified in the position 2’ and/or 3’ of a sugar moiety including 2’- and/or 3’-deoxy, 2’,3’-dideoxydidehydro and 2’-β-C-methylated derivatives. Analogues with a changed configuration in the sugar residue and others sugar modifications will be a subject of the part III of the review. Together with the part I it would be a short but possibly comprehensive review of nucleosides’ biological activities. In the group of analogues modified in the position 2’ and/or 3’ of the sugar moiety the following derivatives among others are listed: AZT (zidovudine) – one of the key nucleoside reverse transcriptase inhibitors (NRTI), which are the core of highly active antiretroviral therapy (HAART) against virus HIV; didanosine (ddI) – another potent NRTI with medical importance; stavudine – FDA approved NRTI; zalcitabine – historically important NRTI, however, because of a high mitochondrial toxicity is no longer in use; puromycin – a wide spectrum antibiotic which causes premature chain termination during translation, isolated from Streptomyces alboniger; gemcitabine – chemotherapy medication developed by Eli Lilly and Company and used to treat ovarian, breast, pancreas, bladder cancer and non-small cell lung carcinoma; cordycepin – the most intriguing analogue extracted from Cordyceps sp. known to traditional Chinese medicine (TCM) for centuries, possessing multi-activity against different cancer types; cladribine – used in the treatment of chronic lymphocytic leukemia, cutaneous T-cell lymphoma, hairy cell leukemia and non-Hodgkin’s lymphomas; valopicitabine – a prodrug form of 2’-C-methylcytidine, which was a promising HCV treatment agent, however, it was held during clinical trials and finally sofosbuvir developed by M.J. Sofia from Pharmasset Inc.– a ProTide prodrug form of 2’-deoxy-2’-fluoro-β-C-methyluridine 5’-monosphate, which revolutionized HCV infection therapy.
    Źródło:
    Wiadomości Chemiczne; 2018, 72, 5-6; 245-264
    0043-5104
    2300-0295
    Pojawia się w:
    Wiadomości Chemiczne
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
    Tytuł:
    Wykorzystanie reakcji 1,3-dipolarnej cykloaddycji Huisgena do modyfikacji nukleozydów i ligonukleotydów
    An application of the Huisgen 1,3-dipolar cycloaddition to modify nukleosides and oligonucleotides
    Autorzy:
    Radzikowska, E.
    Powiązania:
    https://bibliotekanauki.pl/articles/171872.pdf
    Data publikacji:
    2011
    Wydawca:
    Polskie Towarzystwo Chemiczne
    Tematy:
    1,3-dipolarna cykloaddycja
    analogi nukleozydów
    chemia click
    synteza modyfikowanych oligonukleotydów
    1,2,3-triazole
    biokoniugaty
    1,3-dipolar cycloaddition
    analogues of nucleosides
    click chemistry
    synthesis of modified oligonucleotide
    bioconjugates
    Opis:
    The 1,3-dipolar cycloaddition reaction between azides and terminal alkynes, known as the Huisgen reaction, constitutes a powerful tool for the synthesis of versatile molecules containing carbon – heteroatom bond. The use of a copper(I) salt in this reaction allowed Sharpless to develop the concept of „click chemistry” [1]. This strategy is based on reactions between small units characterized by mild reaction conditions, versatility, high yields and stereospecificity. The chemistry of nucleic acids and nucleoside analogues is undergoing rapid developments and numerous compounds from these classes of compounds are used in medicinal treatment. Analogues of nucleoside constitute a class of drugs that possesses either anticancer or/and antiviral activity (against HIV, HSV, VZV or HCV viruses) [3]. Many modified oligonucleotides show biological activity. As potential drugs oligonucleotides are employed in antisense, antigen and aptamer strategies. An antisense therapeutic agent acts on the pathogenic mRNA causing inactivation of the target whereas an antigen agent acts on DNA and aptamer on unwanted protein. It is not surprising that number of research groups are trying to join the concept of click chemistry with nucleic acids chemistry. In this way, it is possible to obtain new molecules like base- or sugar-modified nucleosides, nucleosides, bioconjugates and olignucleotides. The copper-catalyzed 1,3-dipolar cycloaddition CuAAC allows to functionalize DNA, for example by labelling it through attaching small molecules to DNA. Two general strategies have been developed for this purpose: presynthetic and postsynthetic labelling. In the presynthetic method nucleotide monomers are labelled before DNA synthesis and purification. In the postsynthetic strategy DNA containing small reactive groups is synthesized first and then it is conjugated with the desired molecules. CuAAC is also a convenient method for the synthesis of modified oligonucleotides in which phosphodiester linkage is replaced by 1,2,3- -triazole or for a solid phase synthesis. Such molecules appear to be useful in medicine, molecular diagnostic (e.g. fluorescent dyes) or mechanistic molecular model in the future.
    Źródło:
    Wiadomości Chemiczne; 2011, 65, 3-4; 207-234
    0043-5104
    2300-0295
    Pojawia się w:
    Wiadomości Chemiczne
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
      Wyświetlanie 1-4 z 4

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies